The dominant negative mutant of Rac1 (Rac1N17) attenuates paclitaxel-evoked apoptosis in melanoma M14 cells through upregulation of Hsp27, which inhibits the downstream drug-elicited caspase-3 activation [13]. Here, RAC1 is linked to melanoma.